Pfizer on track to post best monthly gain in nearly three decades
Despite a threat to vaccine-driven immunity with the recent emergence of the new COVID-19 variant Omicron, $Pfizer(PFE.US$ is on course to record its best monthly gain since Dec. 1991.
Over the past 12 months, the shares of the New York-based pharma giant has climbed ~40.8% well outperforming the broader index, as indicated in the graph below. Driven by the sales of the vaccine it co-developed with $BioNTech(BNTX.US$ , its revenue has more than doubled over the past year.
Pfizer’s performance contrasts with rival vaccine maker $Moderna(MRNA.US$ whose CEO has warned that the COVID-19 vaccines could lose efficacy against Omicron, classified by the World Health Organization (WHO) as a global variant of concern.
However, Pfizer targets both preventative and therapeutic aspects of the disease with its vaccine and the experimental COVID-19 pill Paxlovid, for which the company has already sought U.S. regulatory authorization.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Dr Wickers : Just raise the dividend bigly in a few weeks....
T_shares : PFE mmm-hmmmm, $60 soon?
Ciao
Mooncity : Even if the Covid bonanza for PFE is short lived, it’s made PFE’s balance sheet as good as JNJ’s, JNJ being the Dividend King of drug stocks. I guess the market hasn’t figured out why PFE has been around for about 170 years, with about 330 consecutive quarters of dividends.
James Browny : Are PFE executives selling to lock in their gains?
EEEEgil James Browny: A few are....
http://openinsider.com/search?q=pfe
Aaron_Kelly : Pandemic's are good business. Keep the variants coming!
wild horse : Imagine that!
ceerup : Well that’s not fabulous— after all its stock price has made zero progress over the last 20 years. Not good.
KNJW ceerup: That's why buy & hold is not always the best choice. Happy to be invested since this year.
Baby putsomemusic : Not that the writer said but, PFE is up 19.8% in the last month.
View more comments...